XML 21 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue:      
Total revenue $ 710 $ 625 $ 479
Costs and expenses:      
Cost of goods sold 358 517 690
Research and development 8,562 8,453 5,799
Selling, general and administrative 6,003 5,757 6,395
Total costs and expenses 14,923 14,727 12,884
Operating loss (14,213) (14,102) (12,405)
Other income (expense):      
Interest income 87 118 95
Gain on change in fair value of redemption feature embedded in convertible notes 52
Interest expense (112)
Loss on extinguishment of convertible notes (521)
Other expense (2) (3) 2
Total other income (expense) (496) 115 97
Net loss $ (14,709) $ (13,987) $ (12,308)
Net loss per share, basic and diluted (in dollars per share) $ (2.61) $ (3.28) $ (2.90)
Weighted-average shares used in computing net loss per share, basic and diluted (in shares) 5,644,328 4,264,178 4,240,060
Product [Member]      
Revenue:      
Total revenue $ 182 $ 282 $ 389
Collaboration Agreement [Member]      
Revenue:      
Total revenue $ 528 $ 343 $ 90